AAAAAA
Results:
1-22
|
Results: 22
Authors:
KIM DS
KORTING HC
SCHAFERKORTING M
Citation: Ds. Kim et al., EFFECTS OF GROWTH-FACTORS ON THE PROLIFERATION OF HUMAN KERATINOCYTESAND FIBROBLASTS IN-VITRO, Die Pharmazie, 53(1), 1998, pp. 51-57
Authors:
GYSLER A
SCHAFERKORTING M
Citation: A. Gysler et M. Schaferkorting, BIOTRANSFORMATION AND PERMEATION OF TOPICAL GLUCOCORTICOIDS IN EXCISED HUMAN SKIN AND RECONSTRUCTED EPIDERMIS, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 17-17
Authors:
KLEUSER B
SPIEGEL S
SCHAFERKORTING M
Citation: B. Kleuser et al., 1-ALPHA,25-DIHYDROXYVITAMIN D-3 INHIBITS PROGRAMMED CELL-DEATH BY FORMATION OF SPHINGOSINE-1-PHOSPHATE, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 42-42
Authors:
TRIER U
KLEUSER B
OLAH Z
SCHAFERKORTING M
Citation: U. Trier et al., DETECTION OF RAS MUTATIONS BY MEASUREMENT OF THE INTERACTIONS BETWEENMUTATED RAS AND THE RAF-1 PROTEIN-KINASE BY FLUORESCENCE CORRELATION SPECTROSCOPY, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 48-48
Authors:
KIM DS
KLEUSER B
SCHAFERKORTING M
Citation: Ds. Kim et al., SPHINGOSINE-1-PHOSPHATE INHIBITS PROLIFERATION AND INDUCES DIFFERENTIATION IN HUMAN KERATINOCYTES, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 49-49
Authors:
LANGE K
BADER M
SCHAFERKORTING M
Citation: K. Lange et al., CELLULAR CYTOKINE SYNTHESIS - DIFFERENTIAL-EFFECTS OF TOPICAL GLUCOCORTICOIDS, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 325-325
Authors:
SCHMIDT R
STREIT M
KAISER R
HERZBERG F
SCHIRNER M
SCHRAMM K
KAUFMANN C
HENNEKEN M
SCHAFERKORTING M
THIEL E
KREUSER ED
Citation: R. Schmidt et al., DE-NOVO EXPRESSION OF THE ALPHA-5-BETA-1-FIBRONECTIN RECEPTOR IN HT29COLON-CANCER CELLS REDUCES ACTIVITY OF C-SRC, INCREASE OF C-SRC ACTIVITY BY ATTACHMENT ON FIBRONECTIN, International journal of cancer, 76(1), 1998, pp. 91-98
Authors:
KLIMKE K
SCHAFERKORTING M
Citation: K. Klimke et M. Schaferkorting, INFLUENCE OF KERATIN ON THE EFFICACY OF F LUCONAZOLE, Mycoses, 40, 1997, pp. 43-46
Authors:
GYSLER A
LANGE K
KORTING HC
SCHAFERKORTING M
Citation: A. Gysler et al., PREDNICARBATE BIOTRANSFORMATION IN HUMAN FORESKIN KERATINOCYTES AND FIBROBLASTS, Pharmaceutical research, 14(6), 1997, pp. 793-797
Authors:
LANGE K
GYSLER A
BADER M
KLEUSER B
KORTING HC
SCHAFERKORTING M
Citation: K. Lange et al., PREDNICARBATE VERSUS CONVENTIONAL TOPICAL GLUCOCORTICOIDS - PHARMACODYNAMIC CHARACTERIZATION IN-VITRO, Pharmaceutical research, 14(12), 1997, pp. 1744-1749
Authors:
GYSLER A
SCHAFERKORTING M
Citation: A. Gysler et M. Schaferkorting, PREDNICARBATE BIOTRANSFORMATION IN HUMAN SKIN KERATINOCYTES AND FIBROBLASTS, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 1-1
Authors:
SCHAFERKORTING M
BLECHSCHMIDT J
KORTING HC
Citation: M. Schaferkorting et al., CLINICAL USE OF ORAL NYSTATIN IN THE PREVENTION OF SYSTEMIC CANDIDOSIS IN PATIENTS AT PARTICULAR RISK, Mycoses, 39(9-10), 1996, pp. 329-339
Authors:
SCHAFERKORTING M
SCHMID MH
KORTING HC
Citation: M. Schaferkorting et al., TOPICAL GLUCOCORTICOIDS WITH IMPROVED RISK-BENEFIT RATIO - RATIONALE OF A NEW CONCEPT, Drug safety, 14(6), 1996, pp. 375-385
Authors:
SCHAFERKORTING M
KORTING HC
RITTLER W
OBERMULLER W
Citation: M. Schaferkorting et al., INFLUENCE OF SERUM-PROTEIN BINDING ON THE IN-VITRO ACTIVITY OF ANTIFUNGAL AGENTS, Infection, 23(5), 1995, pp. 292-297
Authors:
KORTING HC
SCHAFERKORTING M
KLOVEKORN W
KLOVEKORN G
MARTIN C
LAUX P
Citation: Hc. Korting et al., COMPARATIVE EFFICACY OF HAMAMELIS DISTILLATE AND HYDROCORTISONE CREAMIN ATOPIC ECZEMA, European Journal of Clinical Pharmacology, 48(6), 1995, pp. 461-465
Authors:
KORTING HC
HULSEBUS E
KERSCHER M
GREBER R
SCHAFERKORTING M
Citation: Hc. Korting et al., DISCRIMINATION OF THE TOXIC POTENTIAL OF CHEMICALLY DIFFERING TOPICALGLUCOCORTICOIDS USING A NEUTRAL RED RELEASE ASSAY WITH HUMAN KERATINOCYTES AND FIBROBLASTS, British journal of dermatology, 133(1), 1995, pp. 54-59
Authors:
SCHAFERKORTING M
KORTING HC
PONCEPOSCHL E
Citation: M. Schaferkorting et al., LIPOSOMAL TRETINOIN FOR UNCOMPLICATED ACNE-VULGARIS, The Clinical investigator, 72(12), 1994, pp. 1086-1091
Authors:
KORTING HC
KERSCHER M
SCHAFERKORTING M
BERCHTENBREITER U
Citation: Hc. Korting et al., INFLUENCE OF TOPICAL ERYTHROMYCIN PREPARATIONS FOR ACNE-VULGARIS ON SKIN SURFACE PH, The Clinical investigator, 71(8), 1993, pp. 644-648
Authors:
SCHAFERKORTING M
Citation: M. Schaferkorting, PHARMACOKINETIC OPTIMIZATION OF ORAL ANTIFUNGAL THERAPY, Clinical pharmacokinetics, 25(4), 1993, pp. 329-341
Authors:
KORTING HC
SCHAFERKORTING M
ZIENICKE H
GEORGII A
OLLERT MW
Citation: Hc. Korting et al., TREATMENT OF TINEA-UNGUIUM WITH MEDIUM AND HIGH-DOSES OF ULTRAMICROSIZE GRISEOFULVIN COMPARED WITH THAT WITH ITRACONAZOLE, Antimicrobial agents and chemotherapy, 37(10), 1993, pp. 2064-2068
Authors:
KORTING HC
SCHAFERKORTING M
HART H
LAUX P
SCHMID M
Citation: Hc. Korting et al., ANTIINFLAMMATORY ACTIVITY OF HAMAMELIS DISTILLATE APPLIED TOPICALLY TO THE SKIN - INFLUENCE OF VEHICLE AND DOSE, European Journal of Clinical Pharmacology, 44(4), 1993, pp. 315-318
Authors:
SCHAFERKORTING M
KORTING HC
KERSCHER MJ
LENHARD S
Citation: M. Schaferkorting et al., PREDNICARBATE ACTIVITY AND BENEFIT RISK RATIO IN RELATION TO OTHER TOPICAL GLUCOCORTICOIDS, Clinical pharmacology and therapeutics, 54(4), 1993, pp. 448-456
Risultati:
1-22
|